BioNTech

E232831
biotechnology company pharmaceutical company public company

BioNTech is a German biotechnology company best known for developing one of the first mRNA-based COVID-19 vaccines in partnership with Pfizer.

Try in SPARQL Jump to: Surface forms Disambiguation Statements Elicitation Referenced by

All labels observed (4)

Label Occurrences
BioNTech canonical 17
BioNTech SE 10
BioNTech Manufacturing GmbH 1

How this entity was disambiguated

Statements (49)

Predicate Object
instanceOf biotechnology company ⓘ
pharmaceutical company ⓘ
public company ⓘ
abbreviation BioNTech SE ⓘ
linked to: BioNTech
areaServed global ⓘ
collaboratesWith Pfizer ⓘ
country Germany ⓘ
developed BNT162b2 ⓘ
Comirnaty ⓘ
linked to: Pfizer–BioNTech
focusesOn cancer immunotherapy ⓘ
infectious diseases ⓘ
mRNA technology ⓘ
personalized cancer vaccines ⓘ
foundedBy Christoph Huber ⓘ
Ozlem Tureci ⓘ
Ugur Sahin ⓘ
foundedInPeriod 2000s ⓘ
hasClinicalTrialsIn infectious diseases ⓘ
oncology ⓘ
hasCollaboration Genentech ⓘ
Roche ⓘ
Sanofi ⓘ
hasKeyPerson Ozlem Tureci ⓘ
Ugur Sahin ⓘ
hasResearchArea antibodies ⓘ
cell therapies ⓘ
mRNA therapeutics ⓘ
small molecule immunomodulators ⓘ
hasSubsidiaryOrAffiliate BioNTech Manufacturing GmbH ⓘ
linked to: BioNTech
hasTechnologyPlatform CAR-T cell therapy platform ⓘ
individualized neoantigen-specific immunotherapy platform ⓘ
mRNA vaccine platform ⓘ
headquartersLocation Germany ⓘ
Mainz ⓘ
Rhineland-Palatinate ⓘ
industry biotechnology ⓘ
immunotherapy ⓘ
oncology ⓘ
pharmaceuticals ⓘ
legalForm Societas Europaea ⓘ
notableFor developing one of the first authorized mRNA COVID-19 vaccines ⓘ
partnerIn Pfizer–BioNTech COVID-19 vaccine collaboration ⓘ
linked to: Pfizer–BioNTech
positionHeld Ozlem Tureci – Chief Medical Officer ⓘ
Ugur Sahin – Chief Executive Officer ⓘ
productType mRNA-based COVID-19 vaccine ⓘ
regulatoryApproval Emergency Use Authorization for COVID-19 vaccine in multiple countries ⓘ
Full approval for Comirnaty in several jurisdictions ⓘ
stockExchange NASDAQ ⓘ
tickerSymbol BNTX ⓘ

How these facts were elicited

Referenced by (29)

Full triples — surface form annotated when it differs from this entity's canonical label.

Katalin Karikó → employer → BioNTech ⓘ
Pfizer → collaboratedWith → BioNTech ⓘ
Katalin Karikó → employer → BioNTech ⓘ
subject linked to: Karikó
BioNTech → abbreviation → BioNTech SE ⓘ
linked to: BioNTech
BioNTech → hasSubsidiaryOrAffiliate → BioNTech Manufacturing GmbH ⓘ
linked to: BioNTech
Pfizer–BioNTech → hasParticipant → BioNTech SE ⓘ
linked to: BioNTech
Pfizer–BioNTech → clinicalTrialPhase3Sponsor → BioNTech SE ⓘ
linked to: BioNTech
Pfizer–BioNTech → hasResearchPartner → BioNTech SE ⓘ
linked to: BioNTech
Fosun Pharma → collaboratesWith → BioNTech ⓘ
Ugur Sahin → coFounderOf → BioNTech ⓘ
Ugur Sahin → chiefExecutiveOfficerOf → BioNTech ⓘ
Ugur Sahin → employer → BioNTech ⓘ
Özlem Türeci → employer → BioNTech ⓘ
subject linked to: Ozlem Tureci
Özlem Türeci → coFounded → BioNTech ⓘ
subject linked to: Ozlem Tureci
Christoph Huber → coFounded → BioNTech ⓘ
Christoph Huber → employer → BioNTech ⓘ
Christoph Huber → memberOf → BioNTech scientific leadership ⓘ
linked to: BioNTech
Ugur Sahin → employer → BioNTech ⓘ
subject linked to: Ugur Sahin – Chief Executive Officer
Ugur Sahin → coFounded → BioNTech ⓘ
subject linked to: Ugur Sahin – Chief Executive Officer
Özlem Türeci → coFounderOf → BioNTech ⓘ
subject linked to: Ozlem Tureci – Chief Medical Officer
Özlem Türeci → employer → BioNTech ⓘ
subject linked to: Ozlem Tureci – Chief Medical Officer
Özlem Türeci → hasEmployer → BioNTech SE ⓘ
subject linked to: Ozlem Tureci – Chief Medical Officer
linked to: BioNTech
BNT162b2 → hasDeveloper → BioNTech ⓘ
BNT162b2 → isCoDevelopedBy → BioNTech SE ⓘ
linked to: BioNTech
BNTX → represents → BioNTech SE ⓘ
linked to: BioNTech
BNTX → hasTickerSymbolFor → BioNTech SE ⓘ
linked to: BioNTech
BNT162b2 → developedBy → BioNTech SE ⓘ
subject linked to: BNTX
linked to: BioNTech
Comirnaty → developedBy → BioNTech SE ⓘ
subject linked to: BNTX
linked to: BioNTech
Genmab A/S → hasCollaborationWith → BioNTech ⓘ
subject linked to: GMAB